1. Home
  2. ALLR vs CLEU Comparison

ALLR vs CLEU Comparison

Compare ALLR & CLEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • CLEU
  • Stock Information
  • Founded
  • ALLR 2004
  • CLEU 2011
  • Country
  • ALLR United States
  • CLEU China
  • Employees
  • ALLR N/A
  • CLEU N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • CLEU Other Consumer Services
  • Sector
  • ALLR Health Care
  • CLEU Real Estate
  • Exchange
  • ALLR Nasdaq
  • CLEU Nasdaq
  • Market Cap
  • ALLR 4.0M
  • CLEU 4.6M
  • IPO Year
  • ALLR N/A
  • CLEU 2020
  • Fundamental
  • Price
  • ALLR $0.85
  • CLEU $0.08
  • Analyst Decision
  • ALLR
  • CLEU
  • Analyst Count
  • ALLR 0
  • CLEU 0
  • Target Price
  • ALLR N/A
  • CLEU N/A
  • AVG Volume (30 Days)
  • ALLR 564.1K
  • CLEU 131.3K
  • Earning Date
  • ALLR 08-04-2025
  • CLEU 01-01-0001
  • Dividend Yield
  • ALLR N/A
  • CLEU N/A
  • EPS Growth
  • ALLR N/A
  • CLEU N/A
  • EPS
  • ALLR N/A
  • CLEU N/A
  • Revenue
  • ALLR N/A
  • CLEU $2,413,409.00
  • Revenue This Year
  • ALLR N/A
  • CLEU N/A
  • Revenue Next Year
  • ALLR N/A
  • CLEU N/A
  • P/E Ratio
  • ALLR N/A
  • CLEU N/A
  • Revenue Growth
  • ALLR N/A
  • CLEU N/A
  • 52 Week Low
  • ALLR $0.61
  • CLEU $0.66
  • 52 Week High
  • ALLR $17.35
  • CLEU $4,164.00
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 39.03
  • CLEU 18.16
  • Support Level
  • ALLR $0.78
  • CLEU $0.87
  • Resistance Level
  • ALLR $0.93
  • CLEU $1.11
  • Average True Range (ATR)
  • ALLR 0.07
  • CLEU 0.19
  • MACD
  • ALLR -0.02
  • CLEU -0.13
  • Stochastic Oscillator
  • ALLR 18.72
  • CLEU 0.36

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

About CLEU China Liberal Education Holdings Limited

China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.

Share on Social Networks: